The New York Entrepreneur

Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results

Read Time:6 Second

The results could pave the way for Pfizer’s drug ponsegromab to become the first-ever approved treatment specifically for cancer cachexia. 

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Berkshire’s stock hasn’t skidded for this long in 15 years. What’s stalling it?
Next post DirecTV, Disney reach deal to end blackout in time for college football